# Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer

> **NCT03085238** · NA · COMPLETED · sponsor: **MTrap, Inc.** · enrollment: 23 (actual)

## Conditions studied

- Ovarian Cancer Stage IIIC
- Ovarian Cancer Stage IV

## Interventions

- **DEVICE:** M-Trap

## Key facts

- **NCT ID:** NCT03085238
- **Lead sponsor:** MTrap, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2018-09-12
- **Final completion:** 2019-12-31
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085238, "Metastatic Tumor Cell Trap Device in Patients With Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03085238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*